Triple negative breast cancer (TNBC) is a subset of breast cancer which lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene PGR and triple-negative breast carcinoma.